Early drug discovery is plagued by nonspecific molecules, which cannot be developed into drugs. These molecules appear active in initial studies, but upon further investigation are not interesting leads. One of the leading sources of these "false positives" is the formation of large aggregates of organic small molecules, which have the unusual property of promiscuously binding and inhibiting enzymes. Such molecules are common among screening libraries, biological reagents, and even known drugs. Despite their prevalence, there are many elementary properties of these particles that remain unknown and the extent of their repercussions beyond drug screening is not yet clear. This work focuses on expanding our understanding of the fundamental ch...
Abstract: Screening in mixtures is a common approach for increasing the efficiency of high-throughpu...
High-throughput and virtual screening are widely used to discover novel leads for drug design. On ex...
Increasing evidence links the misfolding and aberrant self-assembly of proteins with the molecular e...
One of the leading sources of false positives in early drug discovery is the formation of organic sm...
One of the leading sources of false positives in early drug discovery is the formation of organic sm...
In the early phases of drug discovery, high-throughput screening (HTS) has emerged as the dominant t...
Small-molecule aggregates are a leading cause of artifacts in early drug discovery, but little is kn...
High-throughput screening (HTS) is the primary technique for new lead identification in drug discove...
Colloidal aggregates of small molecules are the most common artifact in early drug discovery, seques...
Drug discovery is fuelled by small-molecules, either as tools to interrogate biology or as leads for...
At micromolar concentrations, many small molecules self-associate into colloidal aggregates that non...
Small molecule aggregates are considered nuisance compounds in drug discovery, but their unusual pro...
Small molecule colloidal aggregates adsorb and partially denature proteins, inhibiting them artifact...
Although protein based therapeutics is the fastest growing sector of the pharmaceutical industry, pr...
Small molecule aggregates are considered nuisance compounds in drug discovery, but their unusual pro...
Abstract: Screening in mixtures is a common approach for increasing the efficiency of high-throughpu...
High-throughput and virtual screening are widely used to discover novel leads for drug design. On ex...
Increasing evidence links the misfolding and aberrant self-assembly of proteins with the molecular e...
One of the leading sources of false positives in early drug discovery is the formation of organic sm...
One of the leading sources of false positives in early drug discovery is the formation of organic sm...
In the early phases of drug discovery, high-throughput screening (HTS) has emerged as the dominant t...
Small-molecule aggregates are a leading cause of artifacts in early drug discovery, but little is kn...
High-throughput screening (HTS) is the primary technique for new lead identification in drug discove...
Colloidal aggregates of small molecules are the most common artifact in early drug discovery, seques...
Drug discovery is fuelled by small-molecules, either as tools to interrogate biology or as leads for...
At micromolar concentrations, many small molecules self-associate into colloidal aggregates that non...
Small molecule aggregates are considered nuisance compounds in drug discovery, but their unusual pro...
Small molecule colloidal aggregates adsorb and partially denature proteins, inhibiting them artifact...
Although protein based therapeutics is the fastest growing sector of the pharmaceutical industry, pr...
Small molecule aggregates are considered nuisance compounds in drug discovery, but their unusual pro...
Abstract: Screening in mixtures is a common approach for increasing the efficiency of high-throughpu...
High-throughput and virtual screening are widely used to discover novel leads for drug design. On ex...
Increasing evidence links the misfolding and aberrant self-assembly of proteins with the molecular e...